Search results for: 'DOG-PRA-PRCD'
-
Achromatopsia (CNGA3: c.1931_1933delTGG)
Test code: DOG-ACMHLAchromatopsia, also known as Early Cone Degeneration, causes daytime blindness due to degeneration of the retinal cones. It can be diagnosed in the first few weeks of a puppy's life. Affected dogs become colour blind and photophobic.€49.85 -
Achromatopsia (CNGB3: c.784G>A)
Test code: DOG-ACHM3Achromatopsia, also known as Early Cone Degeneration, causes daytime blindness due to degeneration of the retinal cones. It can be diagnosed in the first few weeks of a puppy's life. Affected dogs become colour blind and photophobic.
€49.85 -
Exercise induced metabolic myopathy (ACADVL: c.1728C.A)
Test code: DOG-EIMMThis condition is caused by a disorder of fatty acid metabolism that reduces energy production in the muscles. Affected dogs show muscle weakness on exertion which can lead to tetraplegia, muscle pain and brownish urine after exercise.€49.85 -
Cystinuria type II-B - Miniature Pinscher
Test code: DOG-CYST2BCystinuria is a disorder that interferes with the proper reabsorption of cystine (an amino acid) in the kidneys leading to the formation of cystine crystals in the urine. Affected dogs have cystine crystals in the kidneys and/or bladder.€49.85 -
Narcolepsy type 1 (HCRTR2: c.160G>A)
Test code: DOG-NARC1Narcolepsy is a genetic disorder caused by a mutation in the orexin receptor. Affected dogs are sleepy and cannot stay awake for long periods. The first signs appear between 4 weeks and 6 months. Narcolepsy is not life-threatening.€49.85 -
Paw self-mutilation syndrome (GDNF: g.70.875.561C>T)
Test code: DOG-AMSAcral Mutilation Syndrome is characterised by sensory neuropathy of the paws causing insensitivity to pain in the distal parts. Affected dogs usually show signs of extremity self-mutilation. Proprioception, motor skills and reflexes remain intact.€49.85 -
Neuroaxonal dystrophy (RNF170: c.367delG)
Test code: DOG-NAD-MASNeuroaxonal dystrophy (NAD) is a group of inherited neurodegenerative diseases characterised by the presence of spheroids (swollen axons) in the central nervous system. In Miniature American Shepherds, this disease manifests itself as a progressive weakening of the hind limbs, an unsteady gait and coordination problems (ataxia). Affected dogs often show these symptoms from young adulthood, leading to increasing difficulty in moving around. NAD can progress slowly, and although the disease is not immediately fatal, it can seriously affect the quality of life of affected dogs, sometimes leading to euthanasia due to the severity of the symptoms.
€49.85 -
Cystinuria type I-A-2 (SLC3A1: c.350delG)
Test code: DOG-CYST1A2Cystinuria is a disorder that interferes with the proper reabsorption of cystine (an amino acid) in the kidneys leading to the formation of cystine crystals in the urine. Affected dogs have cystine crystals in the kidneys and/or bladder.€49.85 -
Narcolepsy type 2 (HCRTR2: c.647-36_647-35insN[226])
Test code: DOG-NARC2Narcolepsy is a genetic disorder caused by a mutation in the orexin receptor. Affected dogs are sleepy and cannot stay awake for long periods. The first signs appear between 4 weeks and 6 months. Narcolepsy is not life-threatening.€78.65 -
Narcolepsy type 3 (HCRTR2: c.1105+5G>A)
Test code: DOG-NARC3Narcolepsy is a genetic disorder caused by a mutation in the orexin receptor. Affected dogs are sleepy and cannot stay awake for long periods. The first signs appear between 4 weeks and 6 months. Narcolepsy is not life-threatening.€49.85